Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Alginate Biosynthesis and Biotechnological Production Read chapter Read first chapter

2018 | OriginalPaper | Chapter

7. Alginate Application for Heart and Cardiovascular Diseases

Authors : Zhengfan Xu, Mai T. Lam

Published in: Alginates and Their Biomedical Applications

Publisher: Springer Singapore

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Alginate biomaterial has been extensively investigated and used for many biomedical applications due to its biocompatibility, low toxicity, relatively low cost, and ease of use. Its use toward cardiovascular application is no exception. Alginate is approved by the Food and Drug Administration (FDA) for various medical applications, such as a thickening, gel forming, and as a stabilizing agent for dental impression materials, wound dressings, and more. In this chapter, we describe the versatile biomedical applications of alginate, from its use as supporting extracellular matrices (ECM) in patients after acute myocardial infarction (MI), to its employment as a vehicle for stem cell delivery, to controlled delivery of multiple combinations of bioactive molecules. We also cover the application of alginate in creating solutions for treatment of other cardiovascular diseases by capitalizing on the natural properties of alginate to improve creation of heart valves, blood vessels, and drug and stem cell delivery vehicles.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
previous chapter Alginate-Based Three-Dimensional In Vitro Tumor Models: A Better Alternative to Current Two-Dimensional Cell Culture Models
next chapter Alginates in Dressings and Wound Management
Literature
1.
Ueno M, Oda T (2014) Chapter six – biological activities of alginate. Adv Food Nutr Res 72:95–112CrossRef
2.
Laurienzo P (2010) Marine polysaccharides in pharmaceutical applications: an overview. Mar Drugs 8:2435–2465CrossRef
3.
Senni K et al (2011) Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering. Mar Drugs 9:1664–1681CrossRef
4.
Andersen T, Strand BL, Formo K, Alsberg E, Christensen BE (2012) Chapter 9 alginates as biomaterials in tissue engineering. Carbohydr Chem 37:227–258CrossRef
5.
Alsberg E, Anderson KW, Albeiruti A, Franceschi RT, Mooney DJ (2001) Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res 80:2025–2029CrossRef
6.
Boateng JS, Matthews KH, Stevens HN, Eccleston GM (2008) Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97:2892–2923CrossRef
7.
Rabbany SY et al (2010) Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 19:399–408CrossRef
8.
Murakami K et al (2010) Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings. Biomaterials 31:83–90CrossRef
9.
Williams DF (2009) On the nature of biomaterials. Biomaterials 30:5897–5909CrossRef
10.
Martin GSJS, Norman S (2000) Left ventricular remodeling after myocardial infarction pathophysiology and therapy. Circulation 101:2981–2988CrossRef
11.
Westman PC et al (2016) Inflammation and remodeling after myocardial infarction. J Am Coll Cardiol 67:2050–2060CrossRef
12.
Ruvinov E, Sapir Y, Cohen S (2012) Cardiac tissue engineering: principles, materials, and applications. Morgan & Claypool Publishers, San Rafael
13.
Vunjak-Novakovic G, Lui KO, Tandon N, Chien KR (2011) Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 13:245–267CrossRef
14.
Hirt MN, Hansen A, Eschenhagen T (2014) Cardiac tissue engineering: state of the art. Circ Res 114:354–367CrossRef
15.
Akhyari P, Kamiya H, Haverich A, Karck M, Lichtenberg A (2008) Myocardial tissue engineering: the extracellular matrix. Eur J Cardiothorac Surg 34:229–241CrossRef
16.
Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG (2010) The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48:504–511CrossRef
17.
18.
Burdick JA, Mauck RL, Gorman JH, Gorman RC (2013) Acellular biomaterials: an evolving alternative to cell-based therapies. Sci Transl Med 5:174–176CrossRef
19.
Christman KL, Lee RJ (2006) Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48:907–913CrossRef
20.
Rane AA, Christman KL (2011) Biomaterials for the treatment of myocardial infarction: a 5-year update. J Am Coll Cardiol 58:2615–2629CrossRef
21.
Yu J, Christman KL (2009) Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg 137:180–187CrossRef
22.
Yu J, Gu Y, Du KT, Mihardja S, Sievers RE, Lee RJ (2009) The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 30:751–756CrossRef
23.
Sabbah HN et al (2013) Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail 1:252–258CrossRef
24.
Lee LC et al (2013) Algisyl-LVR™ with coronary artery by-pass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol 168:2022–2028CrossRef
25.
Lee RJ et al (2015) The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results. Int J Cardiol 199:18–24CrossRef
26.
Randomized A Controlled study to evaluate algisyl-LVR™ as a method of left ventricular augmentation for heart failure (AUGMENT-HF). http://​ClinicalTrials.​gov, identifier NCT01311791
27.
Rocca et al (2016) An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats. Int J Cardiol 220:149–154CrossRef
28.
Bhana B et al (2010) Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng 105:1148–1160
29.
Engler AJ et al (2008) Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci 121:3794–3802CrossRef
30.
Jacot JG, McCulloch AD, Omens JH (2008) Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 95:3479–3487CrossRef
31.
Bajaj P, Tang X, Saif TA, Bashir R (2010) Stiffness of the substrate influences the phenotype of embryonic chicken cardiac myocytes. J Biomed Mater Res A 95:1261–1269CrossRef
32.
Singelyn JM et al (2012) Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol 59:751–763CrossRef
33.
Tsur-Gang O et al (2009) The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 30:189–195CrossRef
34.
Landa N (2008) Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117:1388–1396CrossRef
35.
Leor J et al (2009) Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 54:1014–1023CrossRef
36.
37.
Frey N et al (2014) Intracoronary delivery of injectable bioabsorbable scaffold (ik-5001) to treat left ventricular remodeling after st-elevation myocardial infarction: a first-in-man study. Circ Cardiovasc Interv 7:806–812CrossRef
38.
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction (PRESERVATION 1). http://​ClinicalTrials.​gov, identifier NCT01226563
39.
Rao SV et al (2016) Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction. J Am Coll Cardiol 68:715–723CrossRef
40.
Segers VF, Lee RT (2011) Biomaterials to enhance stem cell function in the heart. Circ Res 109:910–922CrossRef
41.
Templin C, Luscher TF, Landmesser U (2011) Cell-based cardiovascular repair and regeneration in acute myo-cardial infarction and chronic ischemic cardiomyopathy – current status and future developments. Int J Dev Biol 55:407–417CrossRef
42.
Singelyn JM, Christman KL (2010) Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res 3:478–486CrossRef
43.
Roche ET et al (2014) Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials 35:6850–6858CrossRef
44.
Levit RD (2013) Cellular encapsulation enhances cardiac repair. J Am Heart Assoc 2:e000367CrossRef
45.
Shapiro L, Cohen S (1997) Novel alginate sponges for cell culture and transplantation. Biomaterials 18:583–590CrossRef
46.
Zmora S, Glicklis R, Cohen S (2002) Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials 23:4087–4094CrossRef
47.
Leor J et al (2000) Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102(Suppl. II):56–61
48.
Dar A, Shachar M, Leor J, Cohen S (2002) Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 80:305–312CrossRef
49.
Rosso F, Giordano A, Barbarisi M, Barbarisi A (2004) From cell–ECM interactions to tissue engineering. J Cell Physiol 199:174–180CrossRef
50.
Shachar M, Tsur-Gang O, Dvir T, Leor J, Cohen S (2011) The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater 7:152–162CrossRef
51.
Sapir Y, Kryukov O, Cohen S (2011) Integration of multiple cell–matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 32:1838–1847CrossRef
52.
Cardin AD, Weintraub HJ (1989) Molecular modeling of protein–glycosaminoglycan interactions. Arteriosclerosis 9:21–32CrossRef
53.
Dvir T et al (2011) Nanowired three-dimensional cardiac patches. Nat Nanotechnol 6:720–725CrossRef
54.
Sapir Y, Polyak B, Cohen S (2014) Cardiac tissue engineering in magnetically actuated scaffolds. Nanotechnology 25:014009CrossRef
55.
Lee K, Silva EA, Mooney DJ (2011) Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8:153–170CrossRef
56.
Maltais S, Tremblay JP (2010) The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res 3:652–662CrossRef
57.
Gnecchi M, Zhang Z, Ni A, Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204–1219CrossRef
58.
Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 50:280–289CrossRef
59.
Ratajczak MZ et al (2012) Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26:1166–1173CrossRef
60.
Camussi G, Deregibus MC, Cantaluppi V (2013) Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 41:283–287CrossRef
61.
Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC (2005) Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 39:363–376CrossRef
62.
Hao X et al (2007) Angiogenic effects of sequential release of VEGF-A(165) and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 75:178–185CrossRef
63.
Banquet S et al (2011) Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 124:1059–1069CrossRef
64.
Ruvinov E, Leor J, Cohen S (2011) The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32:565–578CrossRef
65.
Conti E et al (2004) Insulin like growth factor-1 as a vascular protective factor. Circulation 110:2260–2265CrossRef
66.
Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T (2000) Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106:1511–1519CrossRef
67.
Hausenloy DJ, Yellon DM (2009) Cardioprotective growth factors. Cardiovasc Res 83:179–194CrossRef
68.
Ruvinov E, Leor J, Cohen S (2010) The effects of controlled HGF delivery from an affinity binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 31:4573–4582CrossRef
69.
Dvir T et al (2009) Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 106:14990–14995CrossRef
70.
Rodness J et al (2016) VEGF-loaded microsphere patch for local protein delivery to the ischemic heart. Acta Biomaterialia. pii: S1742-7061(16)30472-X. doi: 10.1016/j.actbio.2016.09.009. [Epub ahead of print]
71.
Henri O et al (2016) Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation 133:1484–1497CrossRef
72.
Kang HK et al (2016) Inducible HGF-secreting human umbilical cord blood-derived MSCs Produced via TALEN-mediated genome editing promoted angiogenesis. Mol Ther 24:1644–1654CrossRef
73.
Bin D, Hockaday AL, Kang KH, Butcher JT (2013) 3d bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A 101:1255–1264
74.
Hockaday LA et al (2012) Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication 4(3):035005CrossRef
75.
Liu Y, Sakai S, Taya M (2016) Engineering tissues with a perfusable vessel-like network using endothelialized alginate hydrogel fiber and spheroid-enclosing microcapsules. Heliyon 2:e00067CrossRef
76.
Kinoshita K et al (2016) Fabrication of multilayered vascular tissues using microfluidic agarose hydrogel platforms. Biotechnology Journal. doi: 10.1002/biot.201600083. [Epub ahead of print]
77.
Jia W et al (2016) Direct 3D bioprinting of perfusable vascular constructs using a blend bioink. Biomaterials 106:58–68CrossRef
78.
Kevadiya BD, Joshi GV, Bajaj HC (2010) Layered bionanocomposites as carrier for procainamide. Int J Pharm 388:280–286CrossRef
79.
Beckerman Z et al (2014) A novel amiodarone-eluting biological glue for reducing post-operative atrial fibrillation: first animal trial. J Cardiovasc Pharmacol Ther 19:481–491CrossRef
80.
81.
Lovich MA, Wei A, Maslov MY, Wu PI, Edelman ER (2011) Local epicardial inotropic drug delivery allows targeted pharmacologic intervention with preservation of myocardial loading conditions. J Pharm Sci 100(11):4993–5006CrossRef
82.
Maslov MY, Edelman ER, Wei AE, Pezone MJ, Lovich MA (2013) High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery. J Control Release 171(2):201–207CrossRef
83.
Maslov MY et al (2014) Myocardial drug distribution generated from local epicardial application: potential impact of cardiac capillary perfusion in a swine model using epinephrine. J Control Release 194:257–265CrossRef
84.
Liu TC, Ismail S, Brennan O, Hastings C, Duffy GP (2013) Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin mediated toxicity. J Tissue Eng Regen Med 7:302–311CrossRef
85.
Terakado S et al (2012) Sodium alginate oligosaccharides attenuate hypertension and associated kidney damage in Dahl salt-sensitive rats fed a high-salt diet. Clin Exp Hypertens 34(2):99–106CrossRef
86.
Ueno M et al (2012) Sodium alginate oligosaccharides attenuate hypertension in spontaneously hypertensive rats fed a low-salt diet. Clin Exp Hypertens 34(5):305–310CrossRef
87.
Moriya C et al (2013) Subcutaneous administration of sodium alginate oligosaccharides prevents salt-induced hypertension in Dahl salt-sensitive rats. Clin Exp Hypertens 35(8):607–613CrossRef
88.
Chen YY et al (2010) Preventive effects of low molecular mass potassium alginate extracted from brown algae on DOCA salt-induced hypertension in rats. Biomed Pharmacother 64:291–295CrossRef
89.
Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling – concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35:569–582CrossRef
90.
Zhang P, Zhang H, Wang H, Wei Y, Hu S (2006) Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats. Artif Organs 30:86–93CrossRef
Metadata
Title
Alginate Application for Heart and Cardiovascular Diseases
Authors
Zhengfan Xu
Mai T. Lam
Copyright Year
2018
Publisher
Springer Singapore
Book
Alginates and Their Biomedical Applications

Print ISBN: 978-981-10-6909-3

Electronic ISBN: 978-981-10-6910-9

Copyright Year: 2018

DOI
https://doi.org/10.1007/978-981-10-6910-9_7

Premium Partners

    Image Credits